Senior Global Medical Affairs Director, Medical Asset Lead, Hematology - Oncology (6 months Fixed Term Contract)IPSEN

Ipsen est un groupe biopharmaceutique mondial de taille moyenne, spécialisé dans les médicaments transformateurs dans trois aires thérapeutiques : l'oncologie, les maladies rares et les neurosciences. Forts de près de 100 ans d'expérience en développement, avec des Hubs mondiaux aux États-Unis, en France et au Royaume-Uni, nous focalisons nos efforts là où les besoins médicaux non satisfaits sont importants, grâce à la recherche et à l'innovation.

Nos équipes passionnées, présentes dans plus de 40 pays, se concentrent sur l'essentiel et s'efforcent chaque jour d'apporter des médicaments aux patients dans 88 pays. Nous construisons un environnement de travail qui met en avant un leadership centré sur l'humain et favorise une culture de collaboration, d'excellence et d'impact. Au sein d'Ipsen, chaque individu est encouragé à être soi-même, à grandir et à s'épanouir aux côtés du succès de l'entreprise. Rejoignez-nous dans notre démarche vers une croissance durable, en créant un impact réel sur les patients et la société.

Pour plus d'informations, visitez notre site web à l'adresse https://www.ipsen.com et suivez nos dernières actualités sur LinkedIn et Instagram.

About the Role: This is a 6-months Fixed Term Contract

The Senior Global Medical Affairs Director, Medical Asset Lead, Hematology - Oncology (6-months Fixed Term Contract) is a key strategic leader responsible for shaping the global medical vision and optimizing the full lifecycle of high-impact medical assets. In this senior role, you will drive the alignment of medical deliverables with the goals of the Global Asset Team.

Your leadership will extend to spearheading cross-functional Medical Asset sub-teams (MEG - Medical and Evidence Generation Team), where you will define, drive, and deliver a comprehensive, integrated medical strategy that aligns seamlessly with R&D, access, commercial, regulatory, manufacturing and key local market plans to support the global asset strategies.

This is a unique opportunity to influence pivotal decision-making and elevate our global impact through every phase of the asset lifecycle, ensuring its value to patients, healthcare providers, and stakeholders worldwide

Main Responsibilities

Key Deliverables:

• Congress: booth content finalization, including unbranded campaign launch, TL touch plan coordination
• EHA 2027 congress sponsorship finalization & preparation
• Early IEGP finalization & support to PFR process
• Publication plan coordination (manuscripts, abstracts/presentations)
• Insight collection plan: urothelial cancer (ad board at ESMO), MDS (ad board before year end), US ad board at ASH
• Data generation: research collaboration to be finalized for melanoma PoC, UC and ISS review coordination
• Development of 2027 training plan
• Coordination of thought leader interactions and insights, cooperative groups, scientific societies & investigational site mapping in collaboration with R&D and country medical affairs
• Publication plan coordination: results for presentation at ASH & related Q&A materials, manuscripts
• Study supervision
• Publication plan coordination: Results for presentation at ASH & related Q&A materials, manuscripts
• Study supervision

Medical Asset Lead responsibilities:

Define and deliver an integrated medical asset strategy and plan for both assets to address patient needs

• Own the overall medical strategy, establishes project goals and leads a cross-functional team to meet the medical objectives.
• Outline an integrated evidence generation plan (IEGP) that shapes the competitive and prescription landscape.
• Integrate and influence the medical content of Knowledge Transfer, Medical Education and Information, Congress Management and KOL/TL engagements.
• Translate the medical plan into an efficiently executable high-level roadmap with clear priorities.
• Oversee GMA-led clinical trial executions, ensure a strong alignment with all functions, and drive operational excellence in execution.
• Accountable for leading MEG in coordination with R&D, market access and commercial activities

Develop and manage strong relationships with internal and external stakeholders

• Role model and ambassador for the Medical Asset Plan and for IPSEN with our internal partners and external collaborators, with representatives from the scientific community and health authorities, and in any interactions with health care practitioners and patients
• Serve as the spokesperson for the Medical Asset Plan, reporting progress, risks and issues to functional and executive leaders.
• Represent the interests of the Medical Asset at the Governance Committee

Manage the respective medical asset budget

• Oversee the medical asset budget, from planning and reporting
• Manage projects prioritization within the budget
• Provide strong insights for arbitration within the activities

Ethics & Compliance

• Complete all above activities within the framework and in compliance with all relevant Ipsen SOPs, external GCPs and guidelines as well as other relevant policies in force within the Ipsen Group or under national and/or international authorities under which jurisdiction Ipsen is operating.

Qualifications

• MD; PhD with strong relevant industry experience
• Extensive experience in Hematology-Oncology
• Extensive pharmaceutical experience in significant clinical/medical leadership or general management positions including working with R&D, market access, commercialization and manufacturing teams leading and influencing teams, both in a direct and indirect setting
• Experience between in-country marketing roles and regional/global brand or franchise leadership positions preferred
• Market-relevant experience of hemato-oncology therapy area, including the competitive landscape and Key External Experts
• International experience preferred.
• Track record of successful product launches within the respective therapy area.
• Strong business and/or medical experience in one of the top 5 European markets (UK, France, Germany, Spain, Italy) or in North America (US, Canada)
• Fluency in Englis

#LI-HYBRID